Spero Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Spero Therapeutics, Inc. (SPRO) is 11.25M

According to Spero Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.25M. This represents a change of -85.64% compared to the average of 78.37M of the last 4 quarters.

Spero Therapeutics, Inc. (SPRO) Historical Enterprise Value (quarterly & annually)

How has SPRO Enterprise Value performed in the past?

The mean historical Enterprise Value of Spero Therapeutics, Inc. over the last ten years is 103.92M. The current 11.25M Enterprise Value has changed -89.17% with respect to the historical average. Over the past ten years (40 quarters), SPRO's Enterprise Value was at its highest in in the September 2021 quarter at 485.93M. The Enterprise Value was at its lowest in in the September 2023 quarter at -24214561.20.

Spero Therapeutics, Inc. (SPRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Spero Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Spero Therapeutics, Inc. (SPRO) Average Enterprise Value

How has SPRO Enterprise Value performed in the past?

The current Enterprise Value of Spero Therapeutics, Inc. (SPRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Spero Therapeutics, Inc. (SPRO) Enterprise Value vs. Peers

How is SPRO’s Enterprise Value compared to its peers?

Spero Therapeutics, Inc.’s Enterprise Value is less than Seres Therapeutics, Inc. (59.94M), greater than VistaGen Therapeutics, Inc. (-8726055.00), greater than Actuate Therapeutics Inc (4.86M), less than Inovio Pharmaceuticals, Inc. (98.52M), greater than Acumen Pharmaceuticals, Inc. (-8185953.00), less than Seer, Inc. (89.06M), less than Cognition Therapeutics, Inc. (35.91M), less than Opus Genetics, Inc. (248.03M), less than TuHURA Biosciences, Inc. (115.71M), less than Corbus Pharmaceuticals Holdings, Inc. (57.10M),

Build a custom stock screener for Spero Therapeutics, Inc. (SPRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spero Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spero Therapeutics, Inc. (SPRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spero Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.